Donor and recipient CMV serostatus and antigenemia after renal transplantation: an analysis of 486 patients.
BACKGROUND: Cytomegalovirus infection in renal transplant recipients is a major clinical problem, with both short and long term sequelae. Infection can occur as a result of reactivation of latent virus or new infection from donor tissues. The impact of donor and recipient serostatus on viremia is w...
Main Authors: | Hughes, D, Hafferty, J, Fulton, L, Friend, P, Devaney, A, Loke, J, Welsh, K, Handa, A, Klenerman, P |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2008
|
Similar Items
-
How Do Donor-recipient CMV Serostatus and Post-hematopoietic Stem Cell Transplantation CMV Reactivation Affect Outcomes in Acute Leukemia Patients?
by: Mohammad Vaezi, et al.
Published: (2016-10-01) -
DETERMINAZIONE DI CMV-ANTIGENEMIA E DI CMV-DNA QUANTITATIVO: TRE ANNI DI ESPERIENZA.
by: A. Rossi, et al.
Published: (2007-09-01) -
Cytomegalovirus Serostatus and Functional Impairment in Liver Transplant Recipients in the Current Era
by: Nina Singh, et al.
Published: (2021-08-01) -
Low-dose valaciclovir prophylaxis against cytomegalovirus disease in renal transplant recipients.
by: Reddy, S, et al.
Published: (2003) -
Patient years lost due to cytomegalovirus serostatus mismatching in the scientific registry of transplant recipients
by: Maheen Z. Abidi, et al.
Published: (2024-01-01)